Renal Cell Carcinoma

Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
What is Renal Cell Carcinoma?

Renal cell carcinoma, also called hypernephroma, is a cancer of the kidneys that forms in the proximal convoluted tubule. In the UK, it is the eighth most common cancer among adults, affecting 9,300 people every year.

Read More

Overview

Feature Articles

Latest Renal Cell Carcinoma News and Research

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

Immune checkpoint inhibitor therapy results in longer treatment-free survival for patients with advanced renal cell carcinoma

Immune checkpoint inhibitor therapy results in longer treatment-free survival for patients with advanced renal cell carcinoma

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Kidney cancer study provides new insights into tumor invasion and metastatic competence

Kidney cancer study provides new insights into tumor invasion and metastatic competence

Underexpression of specific metabolic enzyme is a common feature in kidney cancer, study shows

Underexpression of specific metabolic enzyme is a common feature in kidney cancer, study shows

Researchers explore the impact of venous thromboembolism during surgery for renal cell carcinoma

Researchers explore the impact of venous thromboembolism during surgery for renal cell carcinoma

Analysis finds untapped potential for immunotherapy in older cancer patients

Analysis finds untapped potential for immunotherapy in older cancer patients

Cancer immunotherapies could benefit older patients as much as younger people

Cancer immunotherapies could benefit older patients as much as younger people

Penn study discovers a targetable vulnerability in clear cell renal cell carcinoma

Penn study discovers a targetable vulnerability in clear cell renal cell carcinoma

Study may provide a new therapeutic target for treatment of LUAD patients

Study may provide a new therapeutic target for treatment of LUAD patients

New radiotracer opens the door for advancement of iron-targeted cancer therapies

New radiotracer opens the door for advancement of iron-targeted cancer therapies

Clinical trial demonstrates safety of new approach to treat invasive kidney cancer

Clinical trial demonstrates safety of new approach to treat invasive kidney cancer

Researchers identify the origins of seven types of kidney cancer

Researchers identify the origins of seven types of kidney cancer

Using natural killers from the immune system to target breast cancer cells

Using natural killers from the immune system to target breast cancer cells

New study could help guide oncologists in selecting the best treatment for kidney cancers

New study could help guide oncologists in selecting the best treatment for kidney cancers

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

Baseline brain imaging should be considered in most metastatic kidney cancer patients, study suggests

Baseline brain imaging should be considered in most metastatic kidney cancer patients, study suggests